These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 28241069)
1. Early post-treatment choroidal thickness to alert sunset glow fundus in patients with Vogt-Koyanagi-Harada disease treated with systemic corticosteroids. Hirooka K; Saito W; Namba K; Mizuuchi K; Iwata D; Hashimoto Y; Ishida S PLoS One; 2017; 12(2):e0172612. PubMed ID: 28241069 [TBL] [Abstract][Full Text] [Related]
2. The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease. Park UC; Cho IH; Lee EK; Yu HG Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1203-1211. PubMed ID: 28382438 [TBL] [Abstract][Full Text] [Related]
3. Significant role of the choroidal outer layer during recovery from choroidal thickening in Vogt-Koyanagi-Harada disease patients treated with systemic corticosteroids. Hirooka K; Saito W; Namba K; Mizuuchi K; Iwata D; Hashimoto Y; Ishida S BMC Ophthalmol; 2015 Dec; 15():181. PubMed ID: 26677974 [TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease. Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102 [TBL] [Abstract][Full Text] [Related]
6. A clinical grading system based on ultra-wide field retinal imaging for sunset glow fundus in Vogt-Koyanagi-Harada disease. Lee EK; Lee SY; Yu HG Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):359-68. PubMed ID: 25017008 [TBL] [Abstract][Full Text] [Related]
7. Relationship between choroidal blood flow velocity and choroidal thickness during systemic corticosteroid therapy for Vogt-Koyanagi-Harada disease. Hirooka K; Saito W; Namba K; Takemoto Y; Mizuuchi K; Uno T; Tagawa Y; Hashimoto Y; Ishida S Graefes Arch Clin Exp Ophthalmol; 2015 Apr; 253(4):609-17. PubMed ID: 25619665 [TBL] [Abstract][Full Text] [Related]
9. Polarization-Sensitive Optical Coherence Tomographic Documentation of Choroidal Melanin Loss in Chronic Vogt-Koyanagi-Harada Disease. Miura M; Makita S; Yasuno Y; Tsukahara R; Usui Y; Rao NA; Ikuno Y; Uematsu S; Agawa T; Iwasaki T; Goto H Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4467-4476. PubMed ID: 28863408 [TBL] [Abstract][Full Text] [Related]
10. Predictive Biomarker for Progression Into the Sunset Glow Fundus of Vogt-Koyanagi-Harada Disease, Using Adaptive Binarization of Fundus Photographs. Komuku Y; Ishikawa H; Ide A; Matsuoka T; Fukuyama H; Okadome T; Gomi F Transl Vis Sci Technol; 2020 Oct; 9(11):10. PubMed ID: 33133773 [TBL] [Abstract][Full Text] [Related]
11. Choroidal and Retinal Anatomical Responses Following Systemic Corticosteroid Therapy in Vogt-Koyanagi-Harada Disease Using Swept-Source Optical Coherence Tomography. Jaisankar D; Raman R; Sharma HR; Khandelwal N; Bhende M; Agrawal R; Sridharan S; Biswas J Ocul Immunol Inflamm; 2019; 27(2):235-243. PubMed ID: 28700251 [TBL] [Abstract][Full Text] [Related]
12. Correlation Between Hyperreflective Foci in the Choroid and Choroidal Discoloration in Vogt-Koyanagi-Harada Disease. Kim YH; Togloom A; Oh J Invest Ophthalmol Vis Sci; 2022 Aug; 63(9):27. PubMed ID: 36006654 [TBL] [Abstract][Full Text] [Related]
13. Relationship between retinal lesions and inward choroidal bulging in Vogt-Koyanagi-Harada disease. Hosoda Y; Uji A; Hangai M; Morooka S; Nishijima K; Yoshimura N Am J Ophthalmol; 2014 May; 157(5):1056-63. PubMed ID: 24491415 [TBL] [Abstract][Full Text] [Related]